Close
FINDING CURES TOGETHER<sup>SM</sup>

PCWG Programs and Initiatives

Second AACR Special Conference on Pediatric Cancer:
Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship

November 9-12, 2015
Westin Beach Resort and Spa
Fort Lauderdale, Florida

Conference Co-Chairpersons:

1.jpg
Scott A. Armstrong, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, New York


2.jpg
Charles G. Mullighan, MD
St. Jude Children's Research Hospital, Memphis, Tennessee


3.jpg
Kevin M. Shannon, MD
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California

4.jpg
Kimberly Stegmaier, MD
Dana-Farber Cancer Institute, Boston, Massachusetts

 

This special conference will address the unique issues and challenges in investigating the biologic basis of childhood cancers and translating recent findings into new treatment approaches. Presentations will examine the most recent research on novel strategies for modeling pediatric cancers, basic and applied genomics, and the most difficult to treat pediatric cancers. Strategies for translating basic science findings into treatments with a clinical impact will be featured, including the most up-to-date findings on targeted therapeutics, resistance, and immunotherapy. Advances in our understanding of the early and late effects of treatment will also be featured. In addition to proffered talks from the most highly-rated abstracts during the plenary sessions, a special session will highlight the top research that will be presented as posters. Thirty abstracts will be selected and presenters will have one minute to present one slide to highlight their most exciting findings which can then be discussed in greater depth during the poster sessions themselves. This conference will bring together basic, clinical, and translational researchers in the field of pediatric cancer with expertise ranging from the most recent advances in the basic mechanisms of childhood cancers to the application of these findings in the clinical setting.

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available

AACR-PCWG Past Chairperson, Dr. Lee J. Helman Appointed as
Co-Chairperson on Upcoming Special Conference on Sarcoma

The Basic Science of Sarcoma 

November 3-4, 2015
The Grand America Hotel
Salt Lake City, Utah

Conference Co-chairpersons:
Robert G. Maki, Mount Sinai Medical Center, New York, New York
Angelo Paolo Dei Tos, General Hospital of Treviso, Treviso, Italy
Jonathan A. Fletcher, Brigham and Women’s Hospital, Boston, Massachusetts
Lee J. Helman, National Cancer Institute, Bethesda, Maryland
Brian A. Van Tine, Washington University, St. Louis, Missouri

This AACR special conference will cover emerging topics on the basic biology of sarcomas and connective tissue tumors as a complementary program to the The Connective Tissue Oncology Society 20th Annual Meeting. Join internationally recognized experts and hear the latest about functional genomics using novel sarcoma models, immunotherapy, metabolism, and recently elucidated signaling pathways. This conference will provide a unique opportunity for interactions and exchanges between clinicians and scientists on these important topics.

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available

AACR Think Tank on the Future of Pediatric Cancer Research and Care

October 28-30, 2014
AACR Headquarters
Philadelphia, Pennsylvania

Goal
To convene all pediatric cancer stakeholders to define the challenges and opportunities that exist in pediatric oncology across all specialties, while simultaneously identifying actionable items by which AACR may pursue to enhance the organization's existing support of the field.

Participants
Lee J. Helman, MD
National Cancer Institute
Chairperson, AACR Pediatric Cancer Working Group (PCWG)

Garrett M. Brodeur, MD
Children’s Hospital of Philadelphia
Chairperson-elect, AACR Pediatric Cancer Working Group (PCWG)

Peter C. Adamson, MD
Children’s Hospital of Philadelphia

Gregory T. Armstrong, MD
St. Jude Children’s Hospital

Smita Bhatia, MD
City of Hope

Samuel C. Blackman, MD, PhD
Juno Therapeutics

Hubert N. Caron, MD, PhD
Roche Applied Science

Stella M. Davies, MBBS, PhD
Cincinnati Children’s Hospital Medical Center

Lisa R. Diller, MD
Dana-Farber Cancer Institute

Michael A. Dyer, PhD
St. Jude Children’s Research Hospital

Angelika Eggert, MD
University Children's Hospital of Essen

Maryam Fouladi, MD
Cincinnati Children’s Hospital Medical Center

Nancy Goodman
Kids v Cancer

Katherine A. Janeway, MD
Boston Children’s Hospital

Charles Keller, MD
Oregon Health and Science University

Javed Khan, MD
National Cancer Institute

Heinrich Kovar, PhD
Children’s Cancer Research Institute, Vienna

David M. Langenau, PhD
Harvard University

Elizabeth R. Lawlor, MD, PhD
University of Michigan

Michael P. Link, MD
Stanford University

David Malkin, MD
The Hospital for Sick Children, Toronto

John M. Maris, MD
Children’s Hospital of Philadelphia

Paul S. Meltzer, MD, PhD
National Cancer Institute

Olena Morozova, PhD
University of California, Santa Cruz

Charles G. Mullighan, MD
St. Jude Children’s Research Hospital

D. William Parsons, MD, PhD
Baylor College of Medicine Cancer Center

Sharon E. Plon, MD, PhD
Baylor College of Medicine

Leslie L. Robison, PhD
St. Jude Children’s Research Hospital

Raphaël F. Rousseau, MD, PhD
Genentech

Joshua D. Schiffman, MD
University of Utah Huntsman Cancer Institute

Leonard S. Sender, MD 
Children's Hospital of Orange County Cancer Institute

Susan B. Shurin, MD
National Cancer Institute Center for Global Health

Poul H.B. Sorensen, MD, PhD
British Columbia Cancer Research Center

Kimberly Stegmaier, MD
Dana-Farber Cancer Institute

Patrick J. Sullivan
Team Finn Foundation

Alejandro Sweet-Cordero, MD
Stanford University

Carol J. Thiele, PhD
National Cancer Institute

Lisa W. Tichenor
WWWW Foundation, Inc.

Becky C. Weaver
St. Baldrick's Foundation

Robert J. Wechsler-Reya, PhD
Sanford-Burnham Medical Research Institute

Susan L. Weiner, PhD
Children’s Cause for Cancer Advocacy

Areas of emphasis
Access to care, bioinformatics, clinical trials, data sharing, developmental biology, genetics and genomics, preclinical modeling, precision medicine, prevention strategies, survivorship,
relapse issues

SU2C-St. Baldrick’s Pediatric Cancer Dream Team

                 SU2C-St. Baldrick's dream team




Stand Up To Cancer and St. Baldrick’s Foundation will provide $14.5 million over a four-year period to fund translational pediatric cancer research projects poised to deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators.

Visit the SU2C website to learn more about the Pediatric Cancer Dream Team.

PCWG at the AACR Annual Meeting

View the PCWG program information for past and upcoming AACR Annual Meetings.